drugset / Trial / NCT06067100
U-LABA/ICS Effects on Exercise Performance, Indacaterol
RandomizedCrossoverQuadruple-blindBasic science
Summary
The purpose of the project is to investigate exercise performance in humans following bronchodilation induced by acute inhalation of beta2-agonist indacaterol + mometasonefuroate
Timeline
- Start
- 2024-01-15
- Primary completion
- 2026-07-15
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indacaterol | Other / unclassified | 125 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 500 ug | Inhaled |
| Subject | Mometasonefluroate | Unknown | — | Inhaled |
Indications
No indication recorded.